Increased Whole-Body Adiposity Without a Concomitant Increase in Liver Fat is Not Associated With Augmented Metabolic Dysfunction-Reference-Cited by-同舟云学术

Increased Whole-Body Adiposity Without a Concomitant Increase in Liver Fat is Not Associated With Augmented Metabolic Dysfunction

Published:2010-08 Issue:8 Volume:18 Page:1510-1515
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:

Author:

Magkos Faidon,Fabbrini Elisa,Mohammed B. Selma,Patterson Bruce W.,Klein Samuel

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/oby.2010.90/fullpdf

Reference55 articles.

1. AGA technical review on obesity;Klein;Gastroenterology,2002

2. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report;National Institutes of Health;Obes Res,1998

3. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index;Gallagher;Am J Clin Nutr,2000

4. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?;Gallagher;Am J Epidemiol,1996

5. Weight as a risk factor for clinical diabetes in women;Colditz;Am J Epidemiol,1990

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Fat Accumulation Is Associated With Increased Insulin Secretion Independent of Total, Visceral, and Pancreatic Fat;The Journal of Clinical Endocrinology & Metabolism;2024-08-16

2. Gender‐specific data‐driven adiposity subtypes using deep‐learning‐based abdominal CT segmentation;Obesity;2023-05-08

3. Associations between abdominal obesity indices and pathological features of non‐alcoholic fatty liver disease: Chinese visceral adiposity index;Journal of Gastroenterology and Hepatology;2023-04-26

4. Combining Fat-to-Muscle Ratio and Alanine Aminotransferase/Aspartate Aminotransferase Ratio in the Prediction of Cardiometabolic Risk: A Cross-Sectional Study;Diabetes, Metabolic Syndrome and Obesity;2023-03

5. The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications;Drug Design, Development and Therapy;2023-03